论文信息 - Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis - 字舞流文

Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis

M. Iwamoto | M. Martinho | P. Shaw | D. Montgomery | S. Khalilieh | V. Levine | Azher Hussain | Xiaoli S. Glasgow | A. Cheng | I. Bodrug | Lally Mekokishvili | Candice Bailey-Smith | Vanessa Levine | Sauzanne G Khalilieh | Xiaoli S Glasgow | Marian Iwamoto